glp-1 receptor agonists and cancer risk in adults with obesity In a major new JAMA Oncology study, researchers examined health records from 86,632 adults with obesity, comparing those who used GLP-1 receptor agonists (like semaglutide or tirzepatide) to matched non-users. The findings

GLP 1 drugs are often known for their roles in blood sugar control and weight management But did you know that researchers are also studying their potential effects beyond diabetes and obesity? GLP 1 & GIP Agonists Obesity and Diabetes Management Harrison's updates (22nd Ed.) Dr. Mohan Science's 2023 Breakthrough: GLP 1R Agonists MedChemExpress Weight Reduction with GLP 1 Agonists and Paths for Discontinuation While Maintaining Weight Loss Mapping the effectiveness and risks of GLP 1 receptor agonists Nature Medicine GLP 1 agonists are often called the miracle drug for diabetes and weight management. These medications have many benefits, including cardiovascular and renal protection, blood pressure reduction, and improvements in glucose levels. I've